Niche Lobbying: Specialty Firms Form Coalition To Support Mid-Sized Pharma
Executive Summary
A small group of mid-sized drug manufacturers are organizing an informal working group to help make their voice heard in Washington, D.C
You may also be interested in...
Pharma Sales Growth: 2007 Starts High, But Expected To Taper By Year-End
BOSTON - Despite a strong start to 2007, growth in the pharmaceutical sector is expected to slow for the remainder of the year. According to IMS Health VP-Industry Relations Doug Long, "2007 has been a year that you could characterize as a fast start, slow finish.
NDAs Should Include More Cross-Study Analysis, FDA Says In Draft Guidance
FDA is clarifying that it expects sponsors to provide analysis of efficacy data rather than simply a summary of clinical data as part of the integrated summary of effectiveness in new drug applications
New Look At Ezetimibe Fails To Confirm Vytorin Cancer Signal
Interim data from SHARP and IMPROVE-IT trials fail to show evidence of impact on cancer rates.